devxlogo

FDA grants approval to Subtle Medical’s MRI software

FDA grants approval to Subtle Medical’s MRI software
FDA grants approval to Subtle Medical’s MRI software

Subtle Medical, a leader in AI-powered medical imaging, has received FDA clearance for its SubtleHD software. This approval also marks the launch of Subtle-ELITE, a suite of AI tools designed to improve MRI image quality and speed. The Subtle-ELITE package includes three software solutions: SubtleHD, SubtleSYNTH, and SubtleALIGN.

All three have been FDA-cleared. SubtleHD uses advanced techniques to produce ultra-clear images while enabling faster scans, up to 80% faster in some cases. It can be applied to all body regions.

SubtleSYNTH generates MR imaging contrasts from existing sequences using deep learning. It achieves 100% acceleration and produces STIR images instantly. Currently, it is available for spine STIR, with plans to expand to other body regions.

SubtleALIGN automatically aligns brain MR images to the ideal anatomical position with over 97% accuracy.

fda clears Subtle Medical’s latest tools

This reduces variability and improves consistency across studies.

It currently supports 3D brain sequences and can generate orthogonal reformats. Ajit Shankaranarayanan, PhD, Chief Product Officer at Subtle Medical, stated that Subtle-ELITE offers hospitals and imaging centers a powerful solution to increase efficiency, improve image quality, and optimize workflows without additional hardware costs. Subtle Medical was the first to market with third-party AI-powered image enhancement software.

Their solutions are now deployed in over 16 countries worldwide. The company was founded by Greg Zaharchuk, MD, PhD, a neuroradiologist and professor at Stanford, and Enhao Gong, PhD, a deep learning scientist. The Subtle-ELITE suite is vendor-neutral and compatible with all MRI scanners.

Its key benefits include higher patient throughput, improved ROI, superior patient experience, and extended scanner lifespan. Subtle Medical has been recognized as a CB Insights GenAI 50 company and a two-time CB Insights Top AI 100 and Digital Health 150 company. The company is committed to advancing healthcare through AI-driven innovation.

See also  EverNitro Targets Lower Cost Nitro Brewing

Cameron is a highly regarded contributor in the rapidly evolving fields of artificial intelligence (AI) and machine learning. His articles delve into the theoretical underpinnings of AI, the practical applications of machine learning across industries, ethical considerations of autonomous systems, and the societal impacts of these disruptive technologies.

About Our Editorial Process

At DevX, we’re dedicated to tech entrepreneurship. Our team closely follows industry shifts, new products, AI breakthroughs, technology trends, and funding announcements. Articles undergo thorough editing to ensure accuracy and clarity, reflecting DevX’s style and supporting entrepreneurs in the tech sphere.

See our full editorial policy.